He did not know how to deal with Wall Street for funding (until it was too late) and he did not know how to deal with the ODAC. Lots of excuses but in his mind, it was someone else's fault. I tried to make him admit that the chance for FDA approval was zilch but he dodge that one with BS saying that he cannot speculate until the FDA tells him what they need. They already told him that they need a new trial. He is very adept at dodging. Yes, he is The Dodger. Delcath needs someone with start-up experience at the helm.
Actually the market cap is probably = to the cash that they have right now given that they probably spent $3M in April... but do not expect this to be a bottom. If they closed shop, then maybe, but they will continue to burn cash, and sales actually dropped in Q1 from Q42012. What's up with that? Seriously!
Analysts were actually expecting a small profit in 2 years and a hefty profit in 3 years which could justify the price. However, that will need to be adjusted downward. Do the math, estimate what you think revenue will be like in 3-5 years. Estimate expenses and dilution. Compute profit and estimate growth after that. Put percentages on your estimates and multiple the percentages by the estimates, and then figure out how much you think the company is worth today. Then revise your estimates quarterly. Its pretty easy to estimate expenses, not so easy to estimate revenue.
I just asked investor relations if we were going to receive a Final K-1 for CPNO. Their response was:
It is anticipated at this time that Copano unitholders will receive both a “Final” Copano K-1 (for the period 1/1/13 through closing) and a Kinder K-1 (for the period of closing through 12/31/13.) This will be discussed in more detail in the Form S-4 merger documents that both parties will be filing with the SEC in the coming weeks.
I believe that this means that we will need to declare the adjusted basis. I do not believe that this would require us to declare capital gains or losses until the converted KMP shares are sold.
I followed up with Investor Relations with your question. The response was:
My opinion is that your cost basis (and the related adjustments to that basis historically) should carry over and become the basis of your new units in KMP. So I am not certain that you will need to report even any adjustments currently.
My take: In the end, you can probably handle it any way you want as long as you keep your records straight and pay Uncle Sam at the end of the day, when you sell your converted KMP units.
Which insiders are buying? I have not seen any buys reported by insiders. Also, it really wouldn't mean anything of they did. Several of them ganged up and bought in June of last year in a coordinated effort to jack up the share price prior to dilution. The price was around $1.50.